Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

NexPoint Real Estate ate Finance (NREF) Q3 2026 Earnings Report

223 Followers

NREF Q3 2026 EPS Results

Actual EPS
$0.39
Consensus EPS
$0.40
Beat/Miss
Missed by -$0.00
One Year Ago EPS
$0.51

NREF Q3 2026 Revenue Results

Actual Revenue
$37.59M
Expected Revenue
―
Beat/Miss
―
YoY Revenue Growth
+15.74%

Earnings Announcement Details

Quarter
Q3 2026
Date
11/05/2026
Time
Before Open
Conference Call
Thursday, November 5, 2026
NREF Upcoming Earnings

NexPoint Real Estate ate Finance's next earnings date is estimated for March 4, 2027, based on past reporting schedules.

Q3 2026 Earnings Call Audio

NREF Q3 2026 Earnings Call
0:00 / 0:00

Q3 2026 Earnings Slide Deck

Q3 2026 Earnings Call Summary

Q3 2026
Earnings Call Date:Nov 05, 2026|% Change Since:-9.90%|
Earnings Call Sentiment|Positive

The call was broadly positive. NREF reported EAD and CAD ahead of guidance, maintained a covered dividend, expanded financing capacity, funded new investments at double-digit coupons, and described credit performance and portfolio activity favorably. Management also highlighted a substantial opportunity set in residential solution capital and improving life science and self-storage fundamentals. Offsetting concerns included a $0.65 per-share net loss, a 5.2% sequential decline in book value caused by rate-driven unrealized losses, higher borrower refinancing pressure, increased multifamily delinquencies, and continued multifamily concessions. The highlights significantly outweighed the lowlights.

Company Guidance

For the fourth quarter, earnings available for distribution are guided to $0.42 per diluted share at the midpoint, with a range of $0.37 on the low end and $0.47 on the high end, while cash available for distribution is guided to $0.55 per diluted share at the midpoint, with a range of $0.50 on the low end and $0.60 on the high end; management continues to expect a substantial, if not all, of its return of capital from LYFE in the next quarter or two, plans to redeploy most of it into residential collateral, and expects life science to move back toward roughly one-third of the portfolio over time, with new multifamily deliveries forecasted to bottom near 327,000 units in 2027, well below the roughly 600,000-unit peak in 2024.

  • Earnings Available for Distribution and Cash Available for Distribution IncreasedThird-quarter earnings available for distribution was $0.52 per diluted share, compared to $0.51 in Q3 2025, while cash available for distribution was $0.60 per share, compared to $0.53 in the same period of 2025. Management said both EAD and CAD came in ahead of guidance.
  • Dividend Covered and MaintainedThe company paid a regular dividend of $0.50 per share in the third quarter, covered 1.2x by cash available for distribution. On October 26, 2026, the board declared another $0.50 per share dividend payable for the fourth quarter of 2026.
  • New Investments and Existing Commitments FundedNREF funded a $4 million preferred equity investment in a multifamily property paying a monthly coupon of 14%, a $2.2 million preferred equity investment in a marina at a 13% coupon, and an additional $91.7 million on other existing commitments during the quarter.
  • Expanded Mizuho Financing CapacityNREF upsized its $375 million term loan facility and total return swap with Mizuho Capital Markets to $450 million. The additional capacity was used to fund existing commitments, primarily an $80.5 million bridge loan yielding 14% that paid off at the end of the quarter.
  • Flexible Capital Structure and Debt PaydownFollowing the bridge loan payoff, NREF paid down $52.2 million on its secured facility, lowering the outstanding balance to $397.8 million. Combined with the $27.9 million raised in its Series C Preferred offering, management said the company entered the last quarter of 2026 with what it believes to be one of the cleanest, most flexible capital structures in the commercial mortgage REIT sector.
  • Large and Diversified Investment PortfolioThe portfolio comprised 83 investments with a total outstanding balance of $1 billion. Sector allocation was 40.7% life sciences, 38.3% multifamily, 14% single-family rental, 4.6% storage, 2.2% industrial, and 0.2% marina.
  • Portfolio Credit Metrics and Secured Debt ProfileCollateral on the portfolio was 78.3% stabilized, with 64.7% loan-to-value and a weighted average DSCR of 1.39x. NREF had $913.1 million of debt outstanding at a weighted average cost of 5.8% and a weighted average maturity of two and half years. Secured debt was collateralized by $1.5 billion of collateral, had a weighted average maturity of 2.6 years, and a debt-to-equity ratio of 0.97x.
  • Fourth-Quarter Distribution GuidanceFourth-quarter earnings available for distribution guidance was $0.42 per diluted share at the midpoint, with a range of $0.37 to $0.47. Cash available for distribution guidance was $0.55 per diluted share at the midpoint, with a range of $0.50 to $0.60.
  • Positioned for Higher-for-Longer RatesManagement said new investments are priced at double-digit coupons on a reset basis and that NREF is well-positioned for an environment in which the Fed's target rate was 3.75%-4% and the 10-year Treasury had moved back above 5%.
  • Multifamily Supply Pipeline ImprovingMultifamily construction starts fell more than 40% between 2023 and 2025, and new deliveries are forecasted to bottom near 327,000 units in 2027, well below the roughly 600,000-unit peak in 2024. Management said the falling supply pipeline is expected to restore pricing power.
  • Single-Family Rental Portfolio Performing WellManagement said the single-family rental book continues to perform really well, with significant equity cushion. Management viewed the sector's credit profile as slightly more favorable than multifamily, with rents already in positive territory and less pockets of distress.
  • Life Science Fundamentals ImprovingAcross the life science exposure outside LYFE, fundamentals continued to improve sequentially, particularly in Boston and San Francisco, with 220,000 square feet of new leases signed year-to-date. Management also said demand is broadening beyond traditional lab users to biomanufacturing, onshoring, and AI-driven users requiring power density, floor loads, and lab-grade infrastructure.
  • Expected LYFE Capital Return and RedeploymentAt LYFE, the sponsor's recapitalization process was underway, and management continued to expect a substantial, if not all, return of capital in the next quarter or two. When capital comes back, the plan is to redeploy most of it into residential collateral and move life science back toward roughly one-third of the portfolio over time.
  • Self-Storage Performance and New InvestmentsManagement said self-storage fundamentals troughed in 2025 and that new construction pipelines are well below historical averages. NREF continued adding small mezzanine positions on newly stabilized storage assets at double-digit coupons. The NSP-owned portfolio had occupancy of 93.5% as of September 30, with rents up 600 basis points year-over-year.
  • Pipeline Progress and Dry PowderOf the more than $190 million of NREF investments and more than $225 million of structured product opportunities outlined in April, NREF had closed $280 million of the $415 million pipeline year-to-date and had another $160 million committed over the next 12 months. Management said additional Mizuho capacity and expected repayments provide dry powder to pursue attractive spreads in the fourth quarter and into 2027.
  • Agency Multifamily Solution-Capital OpportunityManagement identified more than $32 billion across roughly 1,000 agency floating-rate multifamily loans originated from 2020 through 2023, with about a quarter of that balance already on special servicer watch lists. NREF is developing a program to provide co-terminous supplemental capital behind existing first liens so sponsors can buy interest-rate caps, fund reserves, and pass refinancing or extension tests.
  • Potential Mid-Teens Returns on Agency Solution CapitalManagement said NREF can underwrite to high single digits with solution capital and, if it can execute the investments with agencies and obtain leverage, that can produce a mid-teens return. Management also said approximately $30 billion of opportunities had been identified.
  • Multifamily Assets Taken Back Are RecoveringManagement said prior multifamily problems were concentrated in two or three loans that NREF had already taken back and consolidated. The Alexander project in Atlanta was 97% leased and 95% occupied, and Ridgeview and Mag & May were also being nursed back to health.
  • Remaining Multifamily Mezzanine and Preferred Positions PerformingManagement said the rest of the multifamily mezzanine and preferred positions were performing well and on schedule. New-construction preferred and mezzanine positions were described as doing extremely well and delivering on schedule and on budget.
  • IQHQ Exposure Has Potential Monetization CatalystsThe IQHQ preferred and revolving credit facility exposure was roughly $350 million collectively. Management said the company was executing on its plan, with good traffic in Boston and San Francisco, while the Alewife asset was a near-term catalyst that could be recapitalized, monetized, or sold and potentially generate excess cash to delever the company and repay some NREF capital.
  • Powered-Shell and Edge-Compute OpportunityManagement said certain IQHQ assets had powered shell that was attracting interest from edge-compute users. The economics were described as strong, and management said this could create an interesting monetization event. The RCF detachment point was roughly $1,100 per square foot and the Series E detachment point was roughly $1,350 per square foot.
  • Holly Springs and Vacaville Business PlansHolly Springs was extended to provide sponsors more capital and time to pursue a build-to-suit campus for a top seven market-cap pharmaceutical company, including a 350,000-square-foot biomanufacturing campus. Vacaville was extended while the sponsor pursued conversion of a biomanufacturing facility into an edge-compute facility supported by an existing solar field and substantial power availability.

NREF Earnings History

NREF earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Mar 04, 20272026 (Q4)0.40-0.48――
Nov 05, 20262026 (Q3)0.400.390.51-22.75% (-0.12)
Aug 06, 20262026 (Q2)0.400.460.436.98% (+0.03)
Apr 30, 20262026 (Q1)0.370.420.412.20% (+0.01)
Feb 26, 20262025 (Q4)0.490.480.83-42.17% (-0.35)
Oct 30, 20252025 (Q3)0.470.510.75-32.00% (-0.24)
Jul 31, 20252025 (Q2)0.460.430.68-36.76% (-0.25)
May 01, 20252025 (Q1)0.490.41-0.46189.13% (+0.87)
Feb 27, 20252024 (Q4)0.760.830.4488.64% (+0.39)
Oct 31, 20242024 (Q3)0.480.750.4374.42% (+0.32)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed